XellSmart
PrivateLast Round
Series C
Extension
Apr 2, 2026
Total Funding Raised
$185.64M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
XellSmart is a biotechnology company that develops clinical-grade, allogeneic, off-the-shelf, iPSC-derived cell therapies for central nervous system diseases such as Parkinson's and ALS.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
XellSmart Comparables
Compare XellSmart with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shanghai UniXell Biotechnology | 87% | |
| Kenai Therapeutics | 85% | |
| Nuwacell Biotechnologies Co., Ltd. | 82% | |
XellSmart Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Apr 2, 2026 | ||||
| Series B | Jan 14, 2026 | ||||
| Series A Extension | Apr 1, 2023 | ||||
| Series A Extension | Nov 8, 2022 | ||||
| Series A | Jan 9, 2022 | ||||
Pre Seed | Sep 8, 2021 |
XellSmart Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Huatai Zijin Investment Co., Ltd. | Series A Extension |
| Fig | Series A Extension |
| Junshan Investment | Series A Extension |
| Oriza Holdings | Series A Extension |
| Tianjin TEDA Science and Technology Investment Co., Ltd. | Pre Seed, Angel |
| YuanBio Venture Capital | Pre Seed |
| Next Capital | Series A Extension, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 63% MoM.
- Apr 2, 2026
$69.1M round led by China Reform Fund.
XellSmart Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about XellSmart's valuation, stock price, and market status.